Results 261 to 270 of about 86,750 (278)

Safety and Efficacy of Recombinant Human α-Galactosidase a Replacement Therapy in Fabry's Disease

New England Journal of Medicine, 2001
Robert J. Desnick, William Wilcox, Nathalie Guffon   +2 more
exaly  

Life Expectancy and Cause of Death in Males and Females With Fabry Disease: Findings From the Fabry Registry

Genetics in Medicine, 2009
Manesh Patel, Roberta Lemay, Stephen Waldek   +2 more
exaly  

Enzyme Replacement Therapy With Agalsidase Alfa in Patients With Fabry's Disease: An Analysis of Registry Data

Lancet, The, 2009
Roberto Giugliani, Aleš Linhart, Frédéric Barbey   +2 more
exaly  

Cardiovascular Events in Patients With Fabry Disease: Natural History Data From the Fabry Registry

Journal of the American College of Cardiology, 2011
Kathleen Nicholls, Manesh Patel, Aleš Linhart   +2 more
exaly  

Fabry-Syndrom (Morbus Fabry, Fabry-Krankheit, Fabry-Anderson- Krankheit, Angiokeratosum corporis diffusum)

2011
openaire   +1 more source

Improvement of Cardiac Function During Enzyme Replacement Therapy in Patients With Fabry Disease

Circulation, 2003
Meinrad Beer, Christoph Wanner, Frank Weidemann   +2 more
exaly  

Anderson-Fabry Disease and Other Lysosomal Storage Disorders

Circulation, 2014
Sherif F Nagueh
exaly  

The Abbreviated Pr Interval of Fabry's Disease

New England Journal of Medicine, 1973
exaly  

Fabry or Anderson Fabry disease.

European heart journal, 2014
openaire   +1 more source

Effects of Agalsidase-β Shortage in Fabry Disease

Nature Reviews Nephrology, 2015
exaly